Fairhaven Wealth Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-441
| Closed | -$229K | – | 121 |
|
2024
Q3 | $229K | Hold |
441
| – | – | 0.07% | 104 |
|
2024
Q2 | $239K | Buy |
441
+1
| +0.2% | +$542 | 0.08% | 101 |
|
2024
Q1 | $228K | Sell |
440
-2
| -0.5% | -$1.04K | 0.08% | 108 |
|
2023
Q4 | $208K | Buy |
+442
| New | +$208K | 0.08% | 102 |
|
2023
Q3 | – | Sell |
-586
| Closed | -$260K | – | 122 |
|
2023
Q2 | $260K | Buy |
+586
| New | +$260K | 0.1% | 92 |
|
2022
Q4 | $309K | Buy |
602
+7
| +1% | +$3.59K | 0.13% | 75 |
|
2022
Q3 | $270K | Buy |
595
+50
| +9% | +$22.7K | 0.12% | 77 |
|
2022
Q2 | $263K | Buy |
545
+135
| +33% | +$65.1K | 0.12% | 82 |
|
2022
Q1 | $201K | Buy |
+410
| New | +$201K | 0.08% | 113 |
|
2021
Q4 | – | Sell |
-563
| Closed | -$210K | – | 124 |
|
2021
Q3 | $210K | Sell |
563
-4
| -0.7% | -$1.49K | 0.09% | 103 |
|
2021
Q2 | $216K | Sell |
567
-6
| -1% | -$2.29K | 0.09% | 105 |
|
2021
Q1 | $206K | Sell |
573
-90
| -14% | -$32.4K | 0.09% | 103 |
|
2020
Q4 | $213K | Buy |
+663
| New | +$213K | 0.09% | 101 |
|
2019
Q2 | – | Sell |
-1,114
| Closed | -$320K | – | 79 |
|
2019
Q1 | $320K | Sell |
1,114
-86
| -7% | -$24.7K | 0.3% | 46 |
|
2018
Q4 | $315K | Buy |
+1,200
| New | +$315K | 0.31% | 46 |
|